U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
TROY, Mich., Oct. 06, 2016 -- DirectRx Pharmacy, a leading independent pharmacy accredited by URAC, ACHC, NABP and WBENC, is one of only a few regional, specialty pharmacies selected to dispense SAMSCA, as part of their defined pharmacy network. SAMSCA is used to treat low sodium levels or hyponatremia.
The selection process for their defined pharmacy network was based upon high performance by DirectRx in areas including time to fill prescriptions, data interpretation and efficiency of procedures. These standards have also made DirectRx the recipient of the Specialty Pharmacy (SRX) accreditation by the ACHC and the URAC validation of excellence in Specialty Pharmacy Management in recent years.
SAMSCA is manufactured by Otsuka America Pharmaceutical, Inc. for the treatment of clinically significant hypervolemic and euvolemic hyponatremia, including patients with heart failure, and Syndrome of Inappropriate Antidiuretic Hormone (SIADH). It is considered a specialty medication and dispensed only by pharmacies proven to provide disease specific clinical monitoring as well as patient compliance and adherence programs.
“We are pleased to be selected as a distributor of a specialty medication such as SAMSCA, which requires carefully coordinated care between the patient, pharmacy and physician,” said Amanda Berishaj PharmD, of DirectRx. “At DirectRx, there are no gaps in patient care between physician and pharmacy because we believe that collaboration and communication are critical to creating favorable treatment outcomes. Our adherence programs assure that patients are regularly measured and monitored so that each one stays on their prescribed regimen and receives the support they need throughout the course of their treatment.”
An SRX dispenses medications which target a specific population with a chronic and sometimes life-threatening disease, including Crohn’s disease/ulcerative colitis, hepatitis C, HIV/AIDS, multiple sclerosis (MS), cancer, psoriasis and rheumatoid arthritis (RA). Specialty Pharmacy includes disease specific clinical monitoring as well as patient compliance and adherence programs.
DirectRx Pharmacy, an independent, family-owned pharmacy accredited by URAC, ACHC, NABP and WBENC, is dedicated to providing patients with unparalleled, personalized pharmaceutical care for their specialty pharmacy needs. Unlike other pharmacies, DirectRx is owned and operated by certified doctors of pharmacy. The company has grown to serve more than 38 states since its inception more than two decades ago. Investments in technology help to drive the best possible patient care and deliver the most accurate data to our partners. www.DirectRx.com
CONTACT: Amanda Berishaj, PharmD, DirectRx (248) 273-0480
